跳至主要内容
临床试验/NCT05494008
NCT05494008已完成不适用

Evaluation of Effectiveness and Safety of Korean Herbal Medicine Treatment Strategy for Outpatients With Post-accident Syndromes After Acute Phase: A Pilot Pragmatic Randomized Controlled Trial

Jaseng Medical Foundation2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年7月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Numeric Rating Scale(NRS) of post-accident syndromes

研究概览

简要总结

This study is a single blind, randomized controlled trail. condition/disease: Post-accident syndromes after acute phase treatment/intervention: herbal medicine treatment strategy

详细描述

The Korean herbal medicine is a complex extract of medicinal herbs prescribed by a Korean medicine doctor who has completed specialized education to diagnose the health condition and symptoms of patients with post-traffic accident syndromes. This treatment is known to relieve the post-accident syndromes and improve health. However, there are no studies examining the efficacy of Korean herbal medicine alone.

So, the investigators will conduct a randomized controlled trials to verify the efficacy and safety of Korean herbal medicine. From July, 2021 to May, 2022, the investigators recruited 40 patients who are suffered from post-accident syndromes with the numeric rating scale(NRS) over 5. For experimental group(the Korean herbal medicine treatment group, n=20), the investigators conducted Korean medicine treatment for 4 weeks(28 days), and for control group(the Non-Korean herbal medicine treatment group, n=20), just Korean medical treatment(acupuncture, pharmacoacupuncture, cupping, and chuna) has been conducted. For these two groups, the investigators compared NRS, Impact of Event Scale-Revised-Korean(IES-R-K), 5-level EuroQol 5-dimension(EQ-5D-5L), Short-Form-12 Health Survey version2(SF-12 v2), and Patient Global Impression of Change(PGIC).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 19-70 years on the date they sign the consent form
  • Patients who have passed more than 8 weeks but less than 24 weeks from the date of the accident on the date they sign the consent form
  • Patients with NRS ≥ 5 for post-accident syndromes
  • Patients who provide consent to participate in the trial and return the informed consent form

排除标准

  • Patients whose pain is not due to a traffic accident but due to an existing disease (hernia of intervertebral discs, spinal canal stenosis, fibromyalgia, etc.)
  • Patients who have undergone surgery due to the current traffic accident
  • Patients with progressive neurological deficits or with severe neurological symptoms
  • Patients with other chronic conditions that may interfere with the interpretation of the therapeutic effects or results: cardiovascular disease, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.
  • Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study
  • Patients with exceeding twice the normal value in liver function tests and kidney function tests in screening tests
  • Patients with kidney or liver/biliary system disease (hepatitis, fatty liver, cirrhosis, liver cancer, biliary obstruction, etc.)
  • Patients with gastrointestinal dysfunction or patients who have had a surgery that may affect drug absorption, such as gastrectomy
  • Patients who are pregnant or planning to become pregnant
  • Patients with a serious mental illness
  • Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
  • Patients who are difficult to complete the research participation agreement
  • Other patients whose participation in the trial is judged by a researcher to be problematic

结局指标

主要结局

Numeric Rating Scale(NRS) of post-accident syndromes

时间窗: Change from baseline to 4 months

The severity of post-accident syndrome will be assessed using NRS. NRS is a scale in which the patient indicates their subjective severity of symptoms as a whole number from 0 to 10. The participant is asked to report their severity of post-accident syndrome using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.

次要结局

  • Drug Consumption(Through study completion, an average of 4 months)
  • Numeric Rating Scale(NRS) of psychiatric complaints of post-accident syndromes(Baseline(week 1-1), week 3-1, week 5, week 9, week 17)
  • Numeric Rating Scale(NRS) of general symptoms of post-accident syndromes(Baseline(week 1-1), week 3-1, week 5, week 9, week 17)
  • Impact of Event Scale-Revised-Korean (IES-R-K)(Baseline(week 1-1), week 3-1, week 5, week 9, week 17)
  • Numeric Rating Scale(NRS) of musculoskeletal complaints of post-accident syndromes(Baseline(week 1-1), week 3-1, week 5, week 9, week 17)
  • Numeric Rating Scale(NRS) of neurological complaints of post-accident syndromes(Baseline(week 1-1), week 3-1, week 5, week 9, week 17)
  • Numeric Rating Scale(NRS) of digestive systemic complaints of post-accident syndromes(Baseline(week 1-1), week 3-1, week 5, week 9, week 17)
  • Economic evaluation question(Through study completion, an average of 4 months)
  • 5-level EuroQol 5-dimension (EQ-5D-5L)(Baseline(week 1-1), week 3-1, week 5, week 9, week 17)
  • Patient Global Impression of Change (PGIC)(week 5, week 9, week 17)
  • Adverse events(Through study completion, an average of 4 months)
  • Short-Form-12 Health Survey version2 (SF-12 v2)(Baseline(week 1-1), week 3-1, week 5, week 9, week 17)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

In-Hyuk Ha, KMD

Director

Jaseng Medical Foundation

研究点 (2)

Loading locations...

相似试验